We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+21.28%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$3.14B
AUM Growth
+$411M
Cap. Flow
-$74.7M
Cap. Flow %
-2.38%
Top 10 Hldgs %
12.7%
Holding
454
New
42
Increased
88
Reduced
249
Closed
34

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$7.68M
2
OMC icon
Omnicom Group
OMC
+$4.45M
3
UNF icon
Unifirst Corp
UNF
+$3.85M
4
CHX
ChampionX
CHX
+$3.69M
5
AIR icon
AAR Corp
AIR
+$3.59M

Top Sells

Rank Stock Value
1
AJG icon
Arthur J. Gallagher & Co
AJG
+$8.83M
2
PWR icon
Quanta Services
PWR
+$6.43M
3
MSFT icon
Microsoft
MSFT
+$5.27M
4
FE icon
FirstEnergy
FE
+$4.39M
5
CCI icon
Crown Castle
CCI
+$4.19M

Sector Composition

Rank Sector Weight
1 Technology 17.88%
2 Financials 17.5%
3 Industrials 13.65%
4 Consumer Discretionary 13.14%
5 Healthcare 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXO icon
401
ALX Oncology
ALXO
$288M
$476K 0.02%
+5,524
New +$332K
HARP
402
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$475K 0.02%
+2,862
New +$442K
ANSS
403
DELISTED
Ansys
ANSS
$449K 0.01%
1,234
DXCM icon
404
DexCom
DXCM
$33.2B
$447K 0.01%
4,832
TREX icon
405
Trex
TREX
$4.89B
$437K 0.01%
5,222
-17,322
-77% -$1.33M
TRU icon
406
TransUnion
TRU
$15.2B
$432K 0.01%
4,359
AFMD
407
DELISTED
Affimed
AFMD
$413K 0.01%
+7,100
New +$334K
PH icon
408
Parker-Hannifin
PH
$134B
$407K 0.01%
+1,495
New +$370K
STE icon
409
Steris
STE
$23.1B
$364K 0.01%
1,919
DOC
410
DELISTED
PHYSICIANS REALTY TRUST
DOC
$362K 0.01%
20,341
-108,315
-84% -$1.94M
PTCT icon
411
PTC Therapeutics
PTCT
$6.14B
$350K 0.01%
5,740
-1,299
-18% -$76.6K
DPZ icon
412
Domino's
DPZ
$11.5B
$346K 0.01%
902
OLLI icon
413
Ollie's Bargain Outlet
OLLI
$4.81B
$341K 0.01%
4,176
-27,367
-87% -$2.39M
KRYS icon
414
Krystal Biotech
KRYS
$9.64B
$301K 0.01%
5,018
-14,912
-75% -$745K
NVAX icon
415
Novavax
NVAX
$1.3B
$229K 0.01%
2,054
-470
-19% -$50K
HBAN icon
416
Huntington Bancshares
HBAN
$35.3B
$147K ﹤0.01%
+11,663
New +$133K
AKAM icon
417
Akamai
AKAM
$17B
-7,457
Closed -$824K
ALC icon
418
Alcon
ALC
$35.1B
-7,367
Closed -$420K
AMRN
419
Amarin Corp
AMRN
$301M
-6,140
Closed -$517K
EFOR
420
Everforth Inc
EFOR
$1.35B
-5,257
Closed -$334K
BATRK icon
421
Atlanta Braves Holdings Series B
BATRK
$3.22B
-16,093
Closed -$338K
BDX icon
422
Becton Dickinson
BDX
$48.6B
-2,370
Closed -$538K
BP icon
423
BP
BP
$110B
-121,400
Closed -$2.12M
BSX icon
424
Boston Scientific
BSX
$73.4B
-57,953
Closed -$2.21M
CACI icon
425
CACI
CACI
$14.3B
-17,996
Closed -$3.84M

Similar funds

Chartwell Investment Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Chartwell Investment Partners held 454 positions worth $3.14B, up 15% from $2.73B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Chartwell Investment Partners's Q4 2020 filing shows 42 new, 88 increased, 249 reduced and 34 closed positions. Its largest new stake was Ciena: 172,929 shares worth $9.14M. The largest sale was Arthur J. Gallagher & Co, an estimated $8.83M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.

  • Chartwell Investment Partners's largest Q4 2020 buy was Ciena: 172,929 shares worth $9.14M.
  • Chartwell Investment Partners added most to Unifirst Corp in Q4 2020, an estimated $3.85M increase.
  • Chartwell Investment Partners's biggest Q4 2020 reduction was Arthur J. Gallagher & Co, cutting an estimated $8.83M.
  • Chartwell Investment Partners fully exited FirstEnergy in Q4 2020, selling an estimated $4.39M.
  • Chartwell Investment Partners's ten largest holdings make up 13% of its $3.14B portfolio in Q4 2020.
  • Chartwell Investment Partners opened 42 new positions and closed 34 in Q4 2020.
  • Chartwell Investment Partners's portfolio value rose 15% quarter-over-quarter to $3.14B.

Based on Chartwell Investment Partners's 13F filing for Q4 2020, filed 9 Feb 2021.